Piscataway-based GenScript USA Inc. said Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection ...
(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about the ...
WOBURN, Mass., July 10, 2023 /PRNewswire/ -- Ultrasensitive immunoassays developer Spear Bio is expanding its family of NAB-Sure™ SARS Cov-2 Neutralizing Antibodies test kits. Previously released kits ...
WASHINGTON, D.C. — More than 50 million people in the country are now fully vaccinated against COVID-19. "Most of America is already speeding towards normalcy," said former Baltimore Health ...
SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological ...
SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company, announced today their ...
Some people are worried that another Covid surge is coming, powered by omicron's highly contagious BA.2 subvariant. But experts say a significant jump in cases is unlikely, at least for now — possibly ...
Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because a volunteer has suffered a ...
Invivyd Inc (NASDAQ:IVVD) shares are trading higher after the company released initial results from the ongoing CANOPY Phase 3 pivotal clinical trial of VYD222, a broadly neutralizing, half-life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results